Clinical Trial Update: 18F-FDGal PET/CT and PET/MRI in Patients With Hepatocellular Carcinoma [NA]

View source ↗

Summary

Ongoing clinical study evaluating 18F-FDGal PET/CT and PET/MRI imaging in hepatocellular carcinoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• 18F-FDGal

Snippet

Sponsor: University of Aarhus | Conditions: Hepatocellular Carcinoma | NA | Status: RECRUITING